QL
AKRO

Quarry LP’s Akero Therapeutics AKRO Stock Holding History

Quarry LP’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-837
Closed -$39.7K – 2107
2025
Q3 		$39.7K Buy
+837
New +$40.5K 0.01% 971
2025
Q1 		– Sell
-3,000
Closed -$83.5K – 1611
2024
Q4 		$83.5K Buy
+3,000
New +$90.9K 0.01% 512
2024
Q3 		– Sell
-2,000
Closed -$46.9K – 1605
2024
Q2 		$46.9K Sell
2,000
-950
-32% -$20.3K 0.01% 691
2024
Q1 		$74.5K Buy
2,950
+1,200
+69% +$28.8K 0.01% 305
2023
Q4 		$40.9K Buy
1,750
+500
+40% +$9.86K 0.01% 396
2023
Q3 		$63.2K Buy
+1,250
New +$58.2K 0.01% 274

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Quarry LP's AKRO Position: Q4 2025 in Review

Quarry LP sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 837 shares — an estimated $39.7K sold.

Quarry LP first reported a position in AKRO in Q3 2023 and held it in 6 quarters. The position peaked at $83.5K in Q4 2024. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Quarry LP reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Quarry LP sold 837 Akero Therapeutics shares in Q4 2025, an estimated $39.7K.
  • Quarry LP first reported a position in Akero Therapeutics in Q3 2023 and held it in 6 quarters.
  • Quarry LP's Akero Therapeutics position peaked at $83.5K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Quarry LP's 13F filing for Q4 2025, filed 13 Feb 2026.